Atlas Trials

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT02595931 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02595931
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Pancreatic CarcinomaRefractory Colorectal CarcinomaRefractory Lung Small Cell CarcinomaRefractory Malignant Solid NeoplasmRefractory Pancreatic CarcinomaStage III Colorectal Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8
Start date
2016-07-22
Primary completion
2023-03-07
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.